Healthequity Inc (NASDAQ:HQY) has been given an average recommendation of “Buy” by the thirteen ratings firms that are presently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $58.00.
HQY has been the subject of a number of recent research reports. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $58.00 price objective for the company in a research note on Wednesday, October 11th. BidaskClub raised shares of Healthequity from a “sell” rating to a “hold” rating in a research note on Thursday, September 28th. Cantor Fitzgerald reissued a “buy” rating and issued a $56.00 price objective on shares of Healthequity in a research note on Tuesday, December 5th. Citigroup assumed coverage on shares of Healthequity in a research note on Thursday, January 4th. They issued a “buy” rating for the company. Finally, Chardan Capital upped their price target on Healthequity from $58.00 to $62.00 and gave the stock a “buy” rating in a research report on Wednesday, December 6th.
In other news, major shareholder Berkley Capital, Llc sold 13,600 shares of the company’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $51.02, for a total transaction of $693,872.00. Following the transaction, the insider now directly owns 6,381 shares of the company’s stock, valued at $325,558.62. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Frank Medici sold 32,404 shares of the company’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $51.09, for a total value of $1,655,520.36. Following the transaction, the director now directly owns 6,381 shares in the company, valued at $326,005.29. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,099,034 shares of company stock worth $57,540,059. Insiders own 19.00% of the company’s stock.
Several institutional investors and hedge funds have recently made changes to their positions in the company. Albion Financial Group UT boosted its holdings in Healthequity by 1.4% in the second quarter. Albion Financial Group UT now owns 8,694 shares of the company’s stock valued at $433,000 after purchasing an additional 120 shares during the last quarter. Suntrust Banks Inc. boosted its holdings in Healthequity by 2.7% in the second quarter. Suntrust Banks Inc. now owns 9,408 shares of the company’s stock valued at $468,000 after purchasing an additional 250 shares during the last quarter. NBW Capital LLC boosted its holdings in Healthequity by 0.8% in the second quarter. NBW Capital LLC now owns 37,266 shares of the company’s stock valued at $1,857,000 after purchasing an additional 292 shares during the last quarter. D.A. Davidson & CO. boosted its holdings in Healthequity by 15.2% in the second quarter. D.A. Davidson & CO. now owns 3,326 shares of the company’s stock valued at $165,000 after purchasing an additional 439 shares during the last quarter. Finally, Ameritas Investment Partners Inc. boosted its holdings in Healthequity by 17.4% in the second quarter. Ameritas Investment Partners Inc. now owns 4,375 shares of the company’s stock valued at $218,000 after purchasing an additional 648 shares during the last quarter. 98.07% of the stock is currently owned by hedge funds and other institutional investors.
Healthequity (NASDAQ:HQY) opened at $48.76 on Tuesday. The company has a market cap of $2,960.00, a P/E ratio of 65.89, a P/E/G ratio of 1.99 and a beta of 1.74. Healthequity has a 12 month low of $37.62 and a 12 month high of $55.31.
Healthequity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. The company had revenue of $56.80 million during the quarter, compared to the consensus estimate of $55.27 million. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. Healthequity’s revenue for the quarter was up 31.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.10 earnings per share. equities analysts anticipate that Healthequity will post 0.71 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Healthequity Inc (HQY) Receives Average Rating of “Buy” from Brokerages” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another site, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/02/14/healthequity-inc-hqy-receives-average-rating-of-buy-from-brokerages.html.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.